Clinical trials, research and surveys are open until the quota of participants is met or the study is concluded. We are consistently checking and updating this page. If you come across a study that is closed or no longer accepting participants, please let us know here.
It is the responsibility of each of us with HS to participate in whatever studies, research and surveys possible to further the research and knowledge of HS for ourselves, friends and other warriors currently suffering and those who haven't yet been diagnosed.
**Attention Researchers, Physicians, Pharmaceutical Reps or Sponsors**
If you are interested in listing your clinical trial, please contact us here.
"PARTICIPATE LIKE THE FUTURE OF HS DEPENDS ON IT, BECAUSE IT DOES."
The purpose of the study is to test the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS).